1. Effects of percutaneous kyphoplasty combined with zoledronic acid injection on osteoporotic vertebral compression fracture and bone metabolism indices
- Author
-
Huijun Ning, Tao Chen, Dun Liu, Qingzhong Wei, Jiming Gan, Hongchi Yi, Yuanzhi Zheng, and Zhuoqian Dong
- Subjects
Bone mineral ,medicine.medical_specialty ,Cobb angle ,business.industry ,Visual analogue scale ,Vertebral compression fracture ,Therapeutic effect ,Urology ,Kyphosis ,medicine.disease ,Oswestry Disability Index ,Bone remodeling ,medicine ,Surgery ,Neurology (clinical) ,business - Abstract
BACKGROUND Osteoporotic vertebral compression fracture (OVCF) is usually treated by percutaneous kyphoplasty (PKP) which has limitations. We aimed to evaluate the effects of PKP combined with zoledronic acid (ZOL) injection on OVCF and bone metabolism indices. METHODS A total of 600 OVCF patients admitted from June 2015 to June 2020 were randomly divided into group A (PKP alone), group B (PKP combined with ZOL 1 month later) and group C (PKP concurrently combined with ZOL) (n=200). Before as well as 1 month (before ZOL treatment in group B) and 1 year after PKP, the pain degree, physical function and self-care ability in daily life were assessed, the height and kyphosis Cobb angle of vertebral body with compression fracture and bone mineral densities (BMDs) at different parts were measured, the clinical efficacy, adverse reactions and recurrence of vertebral fractures during 3 years of follow-up were observed, and the serum levels of BAP, BGP, β-CTx and TP1NP were detected. RESULTS Compared with groups A and B, group C had significantly reduced visual analogue scale (VAS) and Oswestry disability index (ODI) scores and raised activity of daily living (ADL) score 1 month after PKP (P
- Published
- 2020
- Full Text
- View/download PDF